IMIDomics
PrivateLast Round
Strategic
Mar 4, 2024
Total Funding Raised
$16.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
IMIDomics operates in Healthcare & Life Sciences and is based in San Rafael, California. Its latest recorded funding round was a Strategic round in March 2024.
IMIDomics is a biotechnology company that develops first-in-class medicines and diagnostic markers for immune-mediated inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IMIDomics Comparables
Compare IMIDomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mirador Therapeutics | 81% | |
| Scipher Medicine | 78% | |
| Immunai | 78% |
For institutional investors. Book with your work email.
IMIDomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Mar 4, 2024 | ||||
| Series A | Jul 27, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
IMIDomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Pritzker Organization | Series A |
| DNS Capital | Series A |
| Tao Capital Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors grew 139% MoM.
- Jun 20, 2026
Monthly visitors grew 298% MoM.
For institutional investors. Book with your work email.
IMIDomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about IMIDomics's valuation, stock price, and market status.
Is IMIDomics a public or private company?
IMIDomics is a private company.
What is the current stock price of IMIDomics?
IMIDomics is a private company, so its shares have no public market price. Caplight tracks IMIDomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is IMIDomics worth (valuation)?
Valuation information for IMIDomics is not publicly available.
Can I buy IMIDomics stock?
IMIDomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was IMIDomics's last funding round?
IMIDomics's most recent funding round was Strategic on March 4, 2024.
Who are the main investors in IMIDomics?
Key investors in IMIDomics include DNS Capital.
Will IMIDomics IPO soon?
No public IPO plans have been announced for IMIDomics.
How can I track IMIDomics secondary market activity?
Caplight tracks bids, offers, and trades in IMIDomics's shares on secondary markets.